Blincyto | Blinatumomab Injection

✓ Breakthrough Bispecific T-cell Engager (BiTE)
✓ Directs patient’s T-cells to destroy CD19+ B-cells
✓ Achieves minimal residual disease (MRD) negativity
✓ Improves overall survival in relapsed ALL
✓ Landmark targeted immunotherapy






%

Save more with Biggest package

This product is currently out of stock and unavailable.

Guaranteed Safe Checkout
Onlinemedex Features:-
  • Premium Quality
  • Secure Payments
  • Satisfaction Guarantee
  • Worldwide Shipping
  • Money Back Guarantee

Fulfilled-using-ems


Generic Name :
Blinatumomab

Drug class:
BiTE (Bispecific T-cell Engager)

CSA Schedule:
Non-controlled drug

Approval:
FDA approved 2014
Save more with Biggest package
BRAND OR GENERIC

GENERIC

STRENGTH

35 mcg per vial

SELECTED PACKAGE

12 Unit(s), 3 Unit(s), 6 Unit(s), 9 Unit(s)

Reviews

There are no reviews yet.

Be the first to review “Blincyto | Blinatumomab Injection”

Your email address will not be published. Required fields are marked *